Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment

Clinical trial NCT02812654 · UNKNOWN

Trial details

NCT number: NCT02812654
Sponsor: AC Camargo Cancer Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Sarcoma, Soft Tissue

Start date: 2015-03-01
Primary completion: 2018-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.